Moira Capital acquires 45.5% of Biorizon Biotech, world leader in bio-technological solutions for ecological agriculture
MOIRAMoira Capital will invest € 10 million to drive the growth of Biorizon Biotech, the world's leading operator in the microalgae-based biostimulants and biopesticides sector. Founded in 2010 in Almería by its CEO David Iglesias, together with Joaquín Pozo, director of R + D + i and Fernando Román, director of marketing and communication, Biorizon Biotech has positioned itself as one of the most innovative operators in the provision of comprehensive solutions for agricultural needs in the biostimulants and bioprotectors sector
All this, taking advantage of the opportunities offered by the global need to increase food production, the requirement to increase crop profitability and the promotion of new regulations that prioritize sustainability criteria.
With the entry of Moira Capital into its shareholding, Biorizon Biotech plans to carry out a strong investment of around € 23 million, in product registrations in strategic markets, as well as in optimizing the largest microalgae and cyanobacteria production plant in Europe, which the company has in Almería. With a presence in seven countries, including Spain, Italy, Portugal, Peru, China, Ecuador, Chile and Morocco, the company plans to continue its internationalization process in southern Europe, Latin America and Asia.
“Biorizon Biotech represents a unique investment opportunity in the incipient and
growing sector of biostimulants and bioprotectors for agricultural application, with one of the world leaders in terms of R&D, productive capacities and range of products, with a profitable and scalable platform, and a top-level management team. ” Says Sebastián Cerezo, partner of Moira Capital.
